Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL522630

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Oc1c(-c2nnc(Cc3ccc(F)cc3)[nH]2)ncc2cccnc12
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL522630
Phase Preclinical
Structure Type MOL
InChI Key VNBMTBOVZFWRAI-UHFFFAOYSA-N
6
Targets
10
Activities
2
Assay Types
0
PK Parameters
10
Publications
0
Known Names

Molecular Properties

321.3
MW (Da)
2.85
ALogP
5
HBA
2
HBD
87.6
PSA (Ų)
0.61
QED
0
Ro5 Violations
3
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C17H12FN5O
MW 321.31
Aromatic Rings 4
Heavy Atoms 24
NP-Likeness -0.88

Activity Summary

IC50 7 meas. best 6.9
EC50 3 meas. best 6.5

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Leishmania donovani
CHEMBL367
 IC50 6.9 5.9 125.9 4
Human immunodeficiency virus type 1 integrase
CHEMBL3471
 IC50 6.89 6.89 130.0 1
Trypanosoma cruzi
CHEMBL368
 IC50 6.8 6.8 158.5 1
Human immunodeficiency virus
CHEMBL613758
 EC50 6.5 6.5 320.0 1
Leishmania donovani
CHEMBL367
 EC50 5.6 5.6 2511.9 1
HepG2
CHEMBL395
 IC50 4.6 4.6 25118.9 1
THP-1
CHEMBL614245
 EC50 4.4 4.4 39810.7 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Leishmania donovani IC50 = 125.89 nM 6.9 GSK_TCAKS: pIC50 Leishmania donovani viability assay using fluorescence intensit... -
Human immunodeficiency virus type 1 integrase IC50 = 130.0 nM 6.89 Inhibition of HIV1 recombinant integrase strand transfer activity 19217781
Trypanosoma cruzi IC50 = 158.49 nM 6.8 GSK_TCAKS: pIC50 Trypanosoma cruzi viability assay using beta-GAL activity. This... -
Human immunodeficiency virus EC50 = 320.0 nM 6.5 Antiviral activity against HIV by pseudo-type HIV assay 19217781
Leishmania donovani IC50 = 1000.0 nM 6.0 GSK_TCAKS: pIC50 Leishmania donovani Imaging: Infected Macrophages. Assay plates... -
Leishmania donovani IC50 = 1000.0 nM 6.0 GSK_TCAKS: pIC50 Leishmania donovani Imaging: Amastigotes/Macrophages. Assay pla... -
Leishmania donovani EC50 = 2511.89 nM 5.6 Antileishmanial activity against Leishmania donovani amastigotes infected in hum... 32663005
Leishmania donovani IC50 = 19952.62 nM 4.7 GSK_TCAKS: pIC50 Leishmania donovani Imaging: THP-1 Host Macrophages. Assay plat... -
HepG2 IC50 = 25118.86 nM 4.6 GSK_TCAKS: pIC50 HepG2 human cell line viability assay using luminiscence. Activ... -
THP-1 EC50 = 39810.72 nM 4.4 Toxicity in human THP1 cells assessed as reduction in cell viability 32663005

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL3430912 Leishmania donovani 4
32663005 10.1021/acs.jmedchem.0c00705 No relevant target 2
19217781 10.1016/j.bmcl.2009.01.090 Human immunodeficiency virus type 1 integrase 1
19217781 10.1016/j.bmcl.2009.01.090 Human immunodeficiency virus 1
- 10.6019/CHEMBL3430912 HepG2 1
- 10.6019/CHEMBL3430912 Trypanosoma cruzi 1
- 10.6019/CHEMBL3430912 Sterol 14-alpha demethylase 1
32663005 10.1021/acs.jmedchem.0c00705 Leishmania donovani 1
32663005 10.1021/acs.jmedchem.0c00705 THP-1 1
32663005 10.1021/acs.jmedchem.0c00705 ADMET 1

Data from ChEMBL 36 via Core Engine